NCT02649621View on ClinicalTrials.gov

The Improvement of Limbal Stem Cell Deficiency (LSCD) in Unilateral Stem Cell Damage by Amniotic Membrane Extract Eye Drop (AMEED)

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

August 31, 2012

Conditions
Limbal Stem Cell Deficiency (LSCD)
Interventions
BIOLOGICAL

Amniotic Membrane Extract Eye Drop (AMEED)

Use of use Amniotic Membrane Extract Eye Drop (AMEED) on in vivo cultured limbal stem cells in the treatment of unilateral corneal stem cell damage.

All Listed Sponsors
lead

Royan Institute

OTHER_GOV

NCT02649621 - The Improvement of Limbal Stem Cell Deficiency (LSCD) in Unilateral Stem Cell Damage by Amniotic Membrane Extract Eye Drop (AMEED) | Biotech Hunter | Biotech Hunter